Article
MTHFR C677T gene polymorphism in patients with coronary heart disease and hypertension treated with enalapril and folic acid: implications for prognosis.
Cellular and molecular biology (Noisy-le-Grand, France) - 8 Oct 2024
Ma Li, Zeng Lanrui, Wang Xiaowen
Abstract excerpt
We aimed to investigate the effect of the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on the prognosis of patients with coronary heart disease (CHD) and hypertension treated with enalapril and folic acid. A total of 540 CHD patients diagnosed by coronary angiography in our hospital were selected. According to whether there was folic acid intervention, they were divided into a folic acid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
